An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes

BMC Family Practice

Volumn 13, Issue , 2012, Pages

  Farmer, Andrew ^a   Hardeman, Wendy ^b   Hughes, Dyfrig ^c   Prevost, A Toby ^d   Kim, Youngsuk ^b   Craven, Anthea ^a   Oke, Jason ^a   Boase, Sue ^b   Selwood, Mary ^a   Kellar, Ian ^b   Graffy, Jonathan ^b   Griffin, Simon ^e   Sutton, Stephen ^b   Kinmonth, Ann Louise ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c BANGOR UNIVERSITY   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e MRC Clinical Epidemiology Unit   (United Kingdom)

Author keywords

Adherence; Brief intervention; Diabetes

Indexed keywords

ANTIDIABETIC AGENT;

AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; DRUG EFFECT; DRUG MONITORING; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH STATUS INDICATOR; HEALTH SURVEY; HUMAN; INSTRUMENTATION; MALE; METHODOLOGY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT REFERRAL; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; STATISTICS; UNITED KINGDOM;

AGED; BLOOD GLUCOSE; DECISION SUPPORT TECHNIQUES; DIABETES MELLITUS, TYPE 2; DRUG MONITORING; ENGLAND; FEMALE; HEALTH STATUS INDICATORS; HEALTH SURVEYS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PRIMARY CARE NURSING; REFERRAL AND CONSULTATION; SELF REPORT;

EID: 84869386304     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-13-30     Document Type: Article

References (29)

1. World Health Organization, Adherence to long-term therapies: evidence for action Geneva: World Health Organisation 2003
2. Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O, N Engl J Med 2003 348 5 383 93 10.1056/NEJMoa021778 12556541 (Pubitemid 36159355)
3. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Hertz RP, Unger AN, Lustik MB, Clin Ther 2005 27 7 1064 73 10.1016/j.clinthera.2005.07.009 16154485 (Pubitemid 41262464)
4. Effect of medication dosing frequency on adherence in chronic diseases. Saini SD, Schoenfeld P, Kaulback K, Dubinsky MC, Am J Manag Care 2009 15 6 22 33 19514806
5. A Systematic Review of Adherence With Medications for Diabetes. Cramer JA, Diabetes Care 2004 27 5 1218 24 10.2337/diacare.27.5.1218 15111553 (Pubitemid 38579798)
6. Costs of medication nonadherence in patients with diabetes mellitus: a systematic review and critical analysis of the literature. Salas M, Hughes D, Zuluaga A, Vardeva K, Lebmeier M, Value Health 2009 12 6 915 22 10.1111/j.1524-4733.2009.00539.x 19402848
7. Medication adherence: its importance in cardiovascular outcomes. Ho PM, Bryson CL, Rumsfeld JS, Circulation 2009 119 23 3028 35 10.1161/CIRCULATIONAHA. 108.768986 19528344
8. Interventions for enhancing medication adherence. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X, Cochrane Database Syst Rev 2008 2 2 D000011 18425859
9. Should we consider non-compliance a medical error? Barber N, Qual Saf Health Care 2002 11 1 81 4 10.1136/qhc.11.1.81 12078377 (Pubitemid 35265308)
10. Protocol for SAMS (Support and Advice for Medication Study): a randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication. Farmer AJ, Prevost AT, Hardeman W, Craven A, Sutton S, Griffin SJ, et al. BMC Fam Pract 2008 9 20 10.1186/1471-2296-9-20 18405345 (Pubitemid 351641904)
11. The theory of planned behaviour. Ajzen I, Organ Behav Hum Decis Process 1991 50 179 211 10.1016/0749-5978(91)90020-T
12. Implementation intentions: strong effects of simple plans. Gollwitzer PM, Am Psychol 1999 54 493 503
13. The impact of compliance in pharmacokinetic studies. Vrijens B, Goetghebeur E, Stat Meth Med Res 1999 8 247 62 10.1191/096228099669221405 (Pubitemid 30005355)
14. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Ware J, Kosinski M, Keller SD, Med Care 1996 34 0025-7079; 3 220 33 8628042 (Pubitemid 126433231)
15. Health belief scales developed specifically for people with tablet-treated type 2 diabetes. Lewis KS, Jennings AM, Ward JD, Bradley C, Diabet Med 1990 7 148 55 2137756 (Pubitemid 20047216)
16. Predicting treatment adherence: an overview of theoretical models. Horne R, Weinman J, Adherence to treatment in medical conditions Harwood Academic, London, UK, Myers L, Midence K, 1998 25 50
17. Measuring beliefs about taking hypoglycaemic medication among people with Type 2 diabetes. Farmer A, Kinmonth AL, Sutton S, Diabet Med 2006 23 3 265 70 10.1111/j.1464-5491.2005.01778.x 16492209
18. Adjusting for partially missing baseline measurements in randomized trials. White IR, Thompson SG, Stat Med 2005 24 0277-6715; 7 993 1007 15570623 (Pubitemid 40426000)
19. Interventions to Enhance Medication Adherence in Chronic Medical Conditions: A Systematic Review. Kripalani S, Yao X, Haynes RB, Arch Intern Med 2007 167 6 540 9 10.1001/archinte.167.6.540 17389285 (Pubitemid 46513223)
20. Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice. Frolkis JP, Pearce GL, Nambi V, Minor S, Sprecher DL, Am J Med 2002 113 8 625 9 10.1016/S0002-9343(02)01303-7 12505111 (Pubitemid 36015797)
21. Run-in periods in randomized trials: implications for the application of results in clinical practice. Pablos-Mendez A, Barr RG, Shea S, JAMA 1998 279 3 222 5 10.1001/jama.279.3.222 9438743 (Pubitemid 28133785)
22. Discontinuation of antihyperlipidemic drugs-do rates reported in clinical trials reflect rates in primary care settings? Andrade SE, Walker AM, Gottlieb LK, Hollenberg NK, Testa MA, Saperia GM, et al. N Engl J Med 1995 332 17 1125 31 10.1056/NEJM199504273321703 7700285
23. Patient adherence and medical treatment outcomes: a meta-analysis. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW, Med Care 2002 40 9 794 811 10.1097/00005650-200209000-00009 12218770
24. Interventions to Enhance Patient Adherence to Medication Prescriptions: Scientific Review. McDonald HP, Garg AX, Haynes RB, JAMA 2002 288 22 2868 679 10.1001/jama.288.22.2868 12472329 (Pubitemid 35425073)
25. A causal modelling approach to the development of theory-based behaviour change programmes for trial evaluation. Hardeman W, Sutton S, Griffin S, Johnston M, White AJ, Wareham NJ, et al. Health Educ Res 2005 20 6 676 87 10.1093/her/cyh022 15781446 (Pubitemid 41567107)
26. Patients decisions about whether or not to take antihypertensive drugs: qualitative study. Benson J, Britten N, BMJ 2002 325 7369 873 10.1136/bmj.325.7369.873 12386041
27. Secondary prevention of coronary heart disease: patient beliefs and health-related behaviour. Byrne M, Walsh J, Murphy AW, J Psychosom Res 2005 58 403 15 10.1016/j.jpsychores.2004.11.010 16026655 (Pubitemid 40982202)
28. Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial. Garber AJ, Duncan TG, Goodman AM, Mills DJ, Rohlf JL, Am J Med 1997 103 491 7 10.1016/S0002-9343(97)00254-4 9428832 (Pubitemid 28018651)
29. Grant P.J., The effects of high and medium dose metformin therapy on cardiovascular risk factors in patients with type II diabetes, Diabetes Care, 1996, 19, 64-66, 10.2337/diacare.19.1.64 8720537